Target price | $10.63 |
Course | $3.00 |
Price potential |
254.17%
register free of charge
|
Number of estimates | 4 |
4 Analysts have issued a price target Relmada Therapeutics Inc 2025 .
The average Relmada Therapeutics Inc target price is $10.63.
This is
254.17%
register free of charge
$25.00
733.33%
register free of charge
$2.00
33.33%
register free of charge
|
|
A rating was issued by 4 analysts: 2 Analysts recommend Relmada Therapeutics Inc to buy, 1 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst estimates: Analysts believe that the Relmada Therapeutics Inc share has an average upside potential 2025 of
254.17%
register free of charge
|
Dec '23 |
2024 Forecast |
|
---|---|---|
Earnings per share $ | -3.28 | -3.17 |
38.11% | 3.35% | |
P/E ratio | negative |
2 Analysts have issued a Relmada Therapeutics Inc forecast for earnings per share. The average Relmada Therapeutics Inc <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Relmada Therapeutics Inc...
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.